Doripenem Dosing Recommendations for Critically Ill Patients Receiving Continuous Renal Replacement Therapy

Antzeko izenburuak

• Influence of Continuous Venovenous Hemofiltration and Continuous Venovenous Hemodiafiltration on the Disposition of Doripenem
  nork: Cirillo, Iolanda, et al.
  Argitaratua: (2011)
• Pharmacokinetic-Pharmacodynamic-Model-Guided Doripenem Dosing in Critically Ill Patients
  nork: Samtani, Mahesh N., et al.
  Argitaratua: (2010)
• Population Pharmacokinetics of Doripenem Based on Data from Phase 1 Studies with Healthy Volunteers and Phase 2 and 3 Studies with Critically Ill Patients
  nork: Nandy, Partha, et al.
  Argitaratua: (2010)
• Open-Label Study To Evaluate the Single-Dose Pharmacokinetics, Safety, and Tolerability of Doripenem in Infants Less than 12 Weeks in Chronological Age
  nork: Cirillo, Iolanda, et al.
  Argitaratua: (2015)
• Drug Dosing Considerations in Critically Ill Patients Receiving Continuous Renal Replacement Therapy
  nork: Jang, Soo Min, et al.
  Argitaratua: (2020)